Fig. 2From: Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBCSurvival outcomes according to newly defined cutoff points for ER and PR expression in ER+/HER2– IBC and corresponding non-IBC. a Distant disease-free survival by ER and PR levels for non-IBC. b Distant disease-free survival by ER and PR levels for IBC c Overall survival by ER and PR levels for non-IBC. d Overall survival by ER and PR levels for IBCBack to article page